AstraZeneca to Buy China's Gracell Bio for up to $1.2 Billion https://ift.tt/DujJaOk cash deal, which adds several experimental therapies to AstraZeneca's portfolio, values Gracell at $2 per ordinary share, or $10 per ADS of Gracell, plus a non-tradable contingent value right of $0.30 per ordinary share, if certain regulatory milestones are met.
Tuesday, December 26, 2023
Subscribe to:
Post Comments (Atom)
Featured Post
-
A simple comparison image of Bing vs. Google Search. The image is divided into two sections: on the left, Bing's logo with a blue back... -
A professional and modern illustration of job seekers searching for jobs on their laptops and smartphones. The scene includes a large job se... -
AMAZON COMPANY - Amazon is the world wide famous American electronic commerce company which headquarters in Seattle, Washington. Amazon...
Posts
No comments:
Post a Comment